MYOVMyovant Sciences Ltd.

NYSE myovant.com


$ 27.00 $ -0.01 (-0.04 %)    

Thursday, 09-Mar-2023 15:59:52 EST
QQQ $ 444.54 $ -0.14 (-0.03 %)
DIA $ 397.60 $ -0.57 (-0.14 %)
SPY $ 523.42 $ 0.18 (0.03 %)
TLT $ 94.99 $ 0.52 (0.55 %)
GLD $ 204.96 $ 0.01 (0 %)
$ 26.98
$ 26.96 x 1,100
$ 27.01 x 2,000
-- - --
$ 7.67 - $ 27.06
2,256,078
na
2.57B
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 01-26-2023 12-31-2022 10-Q
2 10-26-2022 09-30-2022 10-Q
3 07-27-2022 06-30-2022 10-Q
4 05-11-2022 03-31-2022 10-K
5 01-26-2022 12-31-2021 10-Q
6 10-26-2021 09-30-2021 10-Q
7 07-28-2021 06-30-2021 10-Q
8 05-11-2021 03-31-2021 10-K
9 02-11-2021 12-31-2020 10-Q
10 11-12-2020 09-30-2020 10-Q
11 08-11-2020 06-30-2020 10-Q
12 05-18-2020 03-31-2020 10-K
13 02-10-2020 12-31-2019 10-Q
14 11-12-2019 09-30-2019 10-Q
15 08-06-2019 06-30-2019 10-Q
16 05-24-2019 03-31-2019 10-K
17 02-07-2019 12-31-2018 10-Q
18 11-08-2018 09-30-2018 10-Q
19 08-07-2018 06-30-2018 10-Q
20 06-07-2018 03-31-2018 10-K
21 02-13-2018 12-31-2017 10-Q
22 11-13-2017 09-30-2017 10-Q
23 08-10-2017 06-30-2017 10-Q
24 06-14-2017 03-31-2017 10-K
25 02-13-2017 12-31-2016 10-Q
26 12-09-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 myovant-sciences-q3-sales-10020m-miss-10236m-estimate

Myovant Sciences (NYSE:MYOV) reported quarterly sales of $100.20 million which missed the analyst consensus estimate of $102.36...

 looking-into-myovant-sciencess-return-on-invested-capital

Benzinga Pro data, Myovant Sciences (NYSE:MYOV) reported Q2 sales of $104.82 million. Earnings fell to a loss of $45.62 milli...

 myovant-sciences-q2-earnings-insights

Myovant Sciences (NYSE:MYOV) reported its Q2 earnings results on Wednesday, October 26, 2022 at 08:30 AM. Here's what inve...

 benzingas-top-ratings-upgrades-downgrades-for-october-26-2022

Upgrades

 myovant-sciences-q2-eps-047-beats-048-estimate-sales-10482m-miss-11045m-estimate

Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48...

 evercore-isi-group-downgrades-myovant-sciences-to-in-line-announces-27-price-target

Evercore ISI Group analyst Joshua Schimmer downgrades Myovant Sciences (NYSE:MYOV) from Outperform to In-Line and announces ...

 earnings-scheduled-for-october-26-2022

Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on rev...

 earnings-outlook-for-myovant-sciences

Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what inv...

 benzingas-top-ratings-upgrades-downgrades-for-october-25-2022

Upgrades

 where-myovant-sciences-stands-with-analysts

Myovant Sciences (NYSE:MYOV) has observed the following analyst ratings within the last quarter:

 us-stock-futures-down-big-tech-earnings-in-focus

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Tuesday after recording gains in the previous ses...

 why-tricida-shares-dipped-around-95-here-are-73-biggest-movers-from-yesterday

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it w...

 avis-budget-scholastic-and-other-big-gainers-from-monday

U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording ...

 svb-leerink-downgrades-myovant-sciences-to-market-perform-raises-price-target-to-27

SVB Leerink analyst Roanna Ruiz downgrades Myovant Sciences (NYSE:MYOV) from Outperform to Market Perform and raises the pri...

 myovant-sciences-cancels-q2-earnings-conference-call-due-to-the-announcement-of-the-pending-merger-with-sumitovant-biopharma-ltd

 Myovant Sciences (NYSE:MYOV) ("Myovant") today announced the cancellation of its earnings conference call for the quar...

 baird-downgrades-myovant-sciences-to-neutral-raises-price-target-to-27

Baird analyst Brian Skorney downgrades Myovant Sciences (NYSE:MYOV) from Outperform to Neutral and raises the price target f...

 why-vaxcyte-shares-are-trading-sharply-higher-here-are-63-stocks-moving-in-mondays-mid-day-session

Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from ...

 us-stocks-mixed-dow-jumps-200-points

U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday.

 why-myovant-sciences-stock-is-moving-higher

Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher Monday after the company announced it will be acquired by Sumitovan...

 tesla-slashes-china-ev-prices-tsmc-joins-embargo-after-nvidia-and-amd-schlumberger-rebrands-as-slb-top-stories-monday-oct-24

Benzinga

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION